Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment

Cellular Signalling

Volumn 26, Issue 12, 2014, Pages 2843-2856

  Nwabo Kamdje, Armel Herve ^a   Seke Etet, Paul Faustin ^b   Vecchio, Lorella ^c   Muller, Jean Marc ^d   Krampera, Mauro ^e   Lukong, Kiven Erique ^f  

^a UNIVERSITY OF NGAOUNDERE   (Cameroon)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITÉ DE POITIERS   (France)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Breast cancer; Chemo resistance; Microenvironment; Signaling pathways; Targeted therapies

Indexed keywords

4 (4 AMINO 5 (7 METHOXY 1H INDOL 2 YL)IMIDAZO[5,1 F][1,2,4]TRIAZIN 7 YL)CYCLOHEXANECARBOXYLIC ACID; AZD 8055; BEVACIZUMAB; BREAST TUMOR KINASE; CARBOPLATIN; CURCUMIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; DACTOLISIB; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EVEROLIMUS; LETROZOLE; MAMMALIAN TARGET OF RAPAMYCIN; MK 0752; N (6,7 DIHYDRO 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL) 2,2 DIMETHYL N' (2,2,3,3,3 PENTAFLUOROPROPYL)PROPANEDIAMIDE; NOTCH RECEPTOR; PALBOCYCLIB; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RAPAMYCIN; RESVERATROL; SONIC HEDGEHOG PROTEIN; TEMSIROLIMUS; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISMODEGIB; WNT PROTEIN; [1 (4 OXO 8 PHENYL 4H 1 BENZOPYRAN 2 YL)MORPHOLINIO]METHOXYSUCCINYLARGINYLGLYCYLASPARTYLSERINE ACETATE; HORMONE;

ABDOMINAL CRAMP; ANTINEOPLASTIC ACTIVITY; BLEEDING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL CYCLE; CELL SURVIVAL; CONSTIPATION; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DRUG POTENTIATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; FATIGUE; HUMAN; HYPOPHOSPHATEMIA; MOLECULAR INTERACTION; MOLECULARLY TARGETED THERAPY; NAUSEA; NEUTROPENIA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECOMMENDED DRUG DOSE; REVIEW; SIGNAL TRANSDUCTION; THROMBOEMBOLISM; TRIPLE NEGATIVE BREAST CANCER; TUMOR INITIATING CELL; TUMOR MICROENVIRONMENT; VOMITING; BREAST NEOPLASMS; FEMALE; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CELL CYCLE; FEMALE; HORMONES; HUMANS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84907879683     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.07.034     Document Type: Review

References (272)

1. Malumbres M., Barbacid M. Nat. Rev. Cancer 2001, 1:222-231.
2. Hirama T., Koeffler H.P. Blood 1995, 86:841-854.
3. Santamaria D., Ortega S. Front. Biosci. 2006, 11:1164-1188.
4. Lee Y.M., Sicinski P. Cell Cycle 2006, 5:2110-2114.
5. Santagata S., Thakkar A., Ergonul A., Wang B., Woo T., Hu R., Harrell J.C., McNamara G., Schwede M., Culhane A.C., Kindelberger D., Rodig S., Richardson A., Schnitt S.J., Tamimi R.M., Ince T.A. J. Clin. Investig. 2014, 124(2):859.
6. Al-Hussaini H., Subramanyam D., Reedijk M., Sridhar S.S. Mol. Cancer Ther. 2011, 10:9-15.
7. Izrailit J., Berman H.K., Datti A., Wrana J.L., Reedijk M. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1714-1719.
8. Lu W., Lin C., Li Y. Cell. Signal. 2014, 26:1303-1309.
9. Huth L., Rose M., Kloubert V., Winkens W., Schlensog M., Hartmann A., et al. BDNF Is Associated with SFRP1 Expression in Luminal and Basal-Like Breast Cancer Cell Lines and Primary Breast Cancer Tissues: A Novel Role in Tumor Suppression?. PLoS One 2014, 9:e102558.
10. Chen Y.J., Kuo C.D., Chen S.H., Chen W.J., Huang W.C., Chao K.S., Liao H.F. PLoS One 2012, 7:e37006.
11. Mao Y., Keller E.T., Garfield D.H., Shen K., Wang J. Cancer Metastasis Rev. 2013, 32:303-315.
12. Nwabo Kamdje A.H., Mosna F., Bifari F., Lisi V., Bassi G., Malpeli G., Ricciardi M., Perbellini O., Scupoli M.T., Pizzolo G., Krampera M. Blood 2011, 118:380-389.
13. Nwabo Kamdje A.H., Bassi G., Pacelli L., Malpeli G., Amati E., Nichele I., Pizzolo G., Krampera M. Blood Cancer J. 2012, 2:e73.
14. Nwabo Kamdje A.H., Krampera M. Blood 2011, 118:6506-6514.
15. Khin S.S., Kitazawa R., Kondo T., Idei Y., Fujimoto M., Haraguchi R., Mori K., Kitazawa S. Cancers (Basel) 2011, 3:982-993.
16. Nurse P.M. Biosci. Rep. 2002, 22:487-499.
17. Malumbres M. J. BUON 2007, 12(Suppl. 1):S45-S52.
18. Nigg E.A. Bioessays 1995, 17:471-480.
19. Satyanarayana A., Kaldis P. Oncogene 2009, 28:2925-2939.
20. Malumbres M., Barbacid M. Nat. Rev. Cancer 2009, 9:153-166.
21. Nakayama K. Bioassays 1998, 20:1020-1029.
22. Shapiro G.I. J. Clin. Oncol. 2006, 24:1770-1783.
23. Sotillo R1., Renner O., Dubus P., Ruiz-Cabello J., Martín-Caballero J., Barbacid M., Carnero A., Malumbres M. Cancer Res. 2005, 65:3846-3852.
24. Lai E.C. Development 2004, 131:965-973.
25. Muskavitch M.A. Dev. Biol. 1994, 166:415-430.
26. Radtke F., Raj K. Nat. Rev. Cancer 2003, 3:756-767.
27. Pintar A., De Biasio A., Popovic M., Ivanova N., Pongor S. Biol. Direct 2007, 2:19.
28. Moloney D.J., Panin V.M., Johnston S.H., et al. Nature 2000, 406:369-375.
29. Zhang Y.W., Luo W.J., Wang H., et al. J. Biol. Chem. 2005, 280:17020-17026.
30. Fortini M.E., Artavanis-Tsakonas S. Cell 1993, 75:1245-1247.
31. Jarriault S., Brou C., Logeat F., Schroeter E.H., Kopan R., Israel A. Nature 1995, 377:355-358.
32. Hsieh J.J., Henkel T., Salmon P., Robey E., Peterson M.G., Hayward S.D. Mol. Cell. Biol. 1996, 16:952-959.
33. Kopan R., Goate A. Genes Dev. 2000, 14:2799-2806.
34. Zhou S., Fujimuro M., Hsieh J.J., Chen L., Miyamoto A., Weinmaster G., Hayward S.D. Mol. Cell 2000, 2400-2410.
35. Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D. Mol. Cell. Biol. 2002, 22:7688-7700.
36. Kopan R. J. Cell Sci. 2002, 115:1095-1097.
37. Ronchini C., Capobianco A.J. Mol. Cell. Biol. 2001, 21:5925-5934.
38. Weng A.P., Millholland J.M., Yashiro-Ohtani Y., Arcangeli M.L., Lau A., Wai C., Del Bianco C., Rodriguez C.G., Sai H., Tobias J., Li Y., Wolfe M.S., Shachaf C., Felsher D., Blacklow S.C., Pear W.S., Aster J.C. Genes Dev. 2006, 20:2096-2109.
39. Oswald F., Liptay S., Adler G., Schmid R.M. Mol. Cell. Biol. 1998, 18:2077-2088.
40. Dievart A., Beaulieu N., Jolicoeur P. Oncogene 1999, 18:5973-5981.
41. Chen Y., Fischer W.H., Gill G.N. J. Biol. Chem. 1997, 272:14110-14114.
42. Artavanis-Tsakonas S., Matsuno K., Fortini M.E. Science 1995, 268:225-232.
43. Egan S.E., St-Pierre B., Leow C.C. Curr. Top. Microbiol. Immunol. 1998, 228:273-324.
44. Ellisen L.W., Bird J., West D.C., et al. Cell 1991, 66:649-661.
45. Weng A.P., Ferrando A.A., Lee W., et al. Science 2004, 306:269-271.
46. Zagouras P., Stifani S., Blaumueller C.M., Carcangiu M.L., Artavanis-Tsakonas S. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:6414-6418.
47. Leethanakul C., Patel V., Gillespie J., et al. Oncogene 2000, 19:3220-3224.
48. Park J.T., Li M., Nakayama K., et al. Cancer Res. 2006, 66:6312-6318.
49. Wang Z., Zhang Y., Li Y., et al. Mol. Cancer Ther. 2006, 5:483-493.
50. Gallahan D., Callahan R. Oncogene 1997, 14:1883-1890.
51. Imatani A., Callahan R. Oncogene 2000, 19:223-231.
52. Stylianou S., Clarke R.B., Brennan K. Cancer Res. 2006, 66:1517-1525.
53. Yamaguchi N., Oyama T., Ito E., et al. Cancer Res. 2008, 68:1881-1888.
54. Reedijk M., Odorcic S., Chang L., et al. Cancer Res. 2005, 65:8530-8537.
55. Dickson B.C., Mulligan A.M., Zhang H., et al. Mod. Pathol. 2007, 20:685-693.
56. Reedijk M., Pinnaduwage D., Dickson B.C., et al. Breast Cancer Res. Treat. 2008, 111:439-448.
57. Pece S., Serresi M., Santolini E., et al. J. Cell Biol. 2004, 167:215-221.
58. Rizzo P., Miao H., D'Souza G., et al. Cancer Res. 2008, 68:5226-5235.
59. Osipo C., Patel P., Rizzo P., et al. Oncogene 2008, 27:5019-5032.
60. Zeng Q., Li S., Chepeha D.B., et al. Cancer Cell 2005, 8:13-23.
61. Funahashi Y., Shawber C.J., Vorontchikhina M., et al. J. Angiogenes. Res. 2010, 2:3.
62. Shawber C.J., Funahashi Y., Francisco E., et al. J. Clin. Invest. 2007, 117:3369-3382.
63. Taylor K.L., Henderson A.M., Hughes C.C. Microvasc. Res. 2002, 64:372-383.
64. Patel N.S., Dobbie M.S., Rochester M., et al. Clin. Cancer Res. 2006, 12:4836-4844.
65. Noguera-Troise I., Daly C., Papadopoulos N.J., et al. Nature 2006, 444:1032-1037.
66. Kesisis G., Touplikiotiy P., Yiannaki E., et al. Annual Meeting: Abstract 1134 2010, American Society of Clinical Oncology.
67. Sridhar S.S., Hedley D., Siu L.L. Mol. Cancer Ther. 2005, 4:677-685.
68. Mittal S., Subramanyam D., Dey D., Kumar R.V., Rangarajan A. Mol. Cancer 2009, 8:128.
69. Weijzen S., Rizzo P., Braid M., et al. Nat. Med. 2002, 8:979-986.
70. Fitzgerald K., Harrington A., Leder P. Oncogene 2000, 19:4191-4198.
71. Liao W.R., Hsieh R.H., Hsu K.W., et al. Carcinogenesis 2007, 28:1867-1876.
72. Mungamuri S.K., Yang X., Thor A.D., Somasundaram K. Cancer Res. 2006, 66:4715-4724.
73. Bonnet D., Dick J.E. Nat. Med. 1997, 3:730-737.
74. Zheng F.M., Long Z.J., Hou Z.J., Luo Y., Xu L.Z., Xia J.L., et al. A novel small molecule aurora kinase inhibitor attenuates breast tumor-initiating cells and overcomes drug resistance. Mol. Cancer Ther. 2014, 13:1991-2003.
75. Singh S.K., Clarke I.D., Terasaki M., et al. Cancer Res. 2003, 63:5821-5828.
76. Dontu G., Jackson K.W., McNicholas E., et al. Breast Cancer Res. 2004, 6:R605-R615.
77. Farnie G., Clarke R.B., Spence K., et al. J. Natl. Cancer Inst. 2007, 99:616-627.
78. Sansone P., Storci G., Giovannini C., et al. Stem Cells 2007, 25:807-815.
79. Sansone P., Storci G., Tavolari S., et al. J. Clin. Invest. 2007, 117:3988-4002.
80. Bane A.L., Pinnaduwage D., Colby S., et al. Breast Cancer Res. Treat. 2009, 117:183-191.
81. Lee C.W., Simin K., Liu Q., et al. Breast Cancer Res. 2008, 10:R97.
82. Sugianto J., Sarode V., Peng Y. Hum. Pathol. 2014, 45(4):802-809.
83. Dang Daniel, Peng Yan Breast Cancer Manag. (Future Med.) 2013, 2:537-544.
84. Logan C.Y., Nusse R. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810. 10.1146/annurev.cellbio.20.010403.113126.
85. Kaler P., Godasi B.N., Augenlicht L., Klampfer L. Cancer Microenviron 2009, 2:69-80.
86. Su H.Y., Lai H.C., Lin Y.W., Liu C.Y., Chen C.K., et al. Int. J. Cancer 2010, 127:555-567. 10.1002/ijc.25083.
87. Khramtsov A.I., Khramtsova G.F., Tretiakova M., Huo D., Olopade O.I., et al. Am. J. Pathol. 2010, 176:2911-2920. 10.2353/ajpath.2010.091125.
88. Zhang J., Li Y., Liu Q., Lu W., Bu G. Oncogene 2010, 29:539-549. 10.1038/onc.2009.339.
89. Lopez-Knowles E., Zardawi S.J., McNeil C.M., Millar E.K., Crea P., et al. Cancer Epidemiol. Biomarkers Prev. 2010, 19:301-309. 10.1158/1055-9965.epi-09-0741.
90. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., et al. Proc. Natl. Acad. Sci. U. S. A. 2010, 97:4262-4266. 10.1073/pnas.060025397.
91. Veeck J., Geisler C., Noetzel E., Alkaya S., Hartmann A., et al. Carcinogenesis 2008, 29:991-998. 10.1093/carcin/bgn076.
92. Zhou X.L., Qin X.R., Zhang X.D., Ye L.H. Acta Pharmacol. Sin. 2010, 31:202-210. 10.1038/aps.2009.200.
93. Kakarala M., Wicha M.S. J. Clin. Oncol. 2008, 26:2813-2820. 10.1200/jco.2008.16.3931.
94. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988. 10.1073/pnas.0530291100.
95. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., et al. Cancer Res. 2005, 65:5506-5511. 10.1158/0008-5472.can-05-0626.
96. Harrison H., Farnie G., Howell S.J., Rock R.E., Stylianou S., et al. Cancer Res. 2010, 70:709-718. 10.1158/0008-5472.can-09-1681.
97. Ayyanan A., Civenni G., Ciarloni L., Morel C., Mueller N., et al. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3799-3804. 10.1073/pnas.0600065103.
98. Vaillant F., Asselin-Labat M.L., Shackleton M., Forrest N.C., Lindeman G.J., et al. Cancer Res. 2008, 68:7711-7717. 10.1158/0008-5472.can-08-1949.
99. Chen M.S., Woodward W.A., Behbod F., Peddibhotla S., Alfaro M.P., et al. J. Cell Sci. 2007, 120:468-477. 10.1242/jcs.03348.
100. Woodward W.A., Chen M.S., Behbod F., Alfaro M.P., Buchholz T.A., et al. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:618-623. 10.1073/pnas.0606599104.
101. Lamb R1., Ablett M.P., Spence K., Landberg G., Sims A.H., Clarke R.B. PLoS One 2013, 4;8(7):e67811. 10.1371/journal.pone.0067811.
102. Parkin D.M., Bray F., Ferlay J., Pisani P. Int. J. Cancer 2001, 15(94):153-156.
103. Nechuta S., Lu W., Zheng Y., et al. Breast Cancer Res. Treat. 2013, 139(1):227-235.
104. Walterhouse D.O., Yoono J.W., Iannaccone P.M. Environ. Health Perspect. 1999, 107(3):167-171.
105. Agathocleous M., Locker M., Harris W.A., Perron M. Cell Cycle 2007, 6(2):156-159.
106. Ingham P.W., McMahon A.P. Gene Dev. 2001, 15(23):3059-3087.
107. García-Zaragoza E., Pérez-Tavarez R., Ballester A., et al. Dev. Biol. 2012, 372(1):28-44.
108. Fiaschi M., Rozell B., Bergström A., Toftgård R., Kleman M.I. J. Biol. Chem. 2007, 282(49):36090-36101.
109. Jeng K.S., Sheen I.S., Jeng W.J., Yu M.C., Hsiau H.I., Chang F.Y. Onco Targets Ther. 2013, 7:79-86.
110. Lee S-K, Shaw AS, Maher SE, Bothwell ALM. p59 fyn tyrosine kinase is an essential regulator of p56lck tyrosine kinase activity and early TcR-mediated signalling.
111. Mitchell P.J., Barker K.T., Martindale J.E., Kamalati T., Lowe P.N., et al. Oncogene 1994, 9:2383-2390.
112. Barker K.T., Jackson L.E., Crompton M.R. Oncogene 1997, 15:799-805. 10.1038/sj.onc.1201241.
113. Ostrander J.H., Daniel A.R., Lofgren K., Kleer C.G., Lange C.A. Cancer Res. 2007, 67:4199-4209.
114. Aubele M., Auer G., Walch A.K., Munro A., Atkinson M.J., et al. Br. J. Cancer 2007, 96:801-807.
115. Easty D.J., Mitchell P.J., Patel K., Flørenes V.A., Spritz R.A., et al. Int. J. Cancer 1997, 71:1061-1065.
116. Llor X., Serfas M.S., Bie W., Vasioukhin V., Polonskaia M., et al. Clin. Cancer Res. 1999, 5:1767-1777.
117. Petro B.J., Tan R.C., Tyner A.L., Lingen M.W., Watanabe K. Oral Oncol. 2004, 40:1040-1047.
118. Derry J.J., Prins G.S., Ray V., Tyner A.L. Oncogene 2003, 22:4212-4220. 10.1038/sj.onc.1206465.
119. Kasprzycka M., Majewski M., Wang Z.J., Ptasznik A., Wysocka M., et al. Am. J. Pathol. 2006, 168:1631-1641. 10.2353/ajpath.2006.050521.
120. Schmandt R.E., Bennett M., Clifford S., Thornton A., Jiang F., et al. Cancer Biol. Ther. 2006, 5:1136-1141. 10.4161/cbt.5.9.2953.
121. Serfas M.S., Tyner A.L. Oncol. Res. 2003, 13:409-419.
122. Derry J.J., Richard S., Carvajal H.V., Ye X., Vasioukhin V., et al. Mol. Cell. Biol. 2000, 20:6114-6126. 10.1128/mcb.20.16.6114-6126.2000.
123. Qiu H., Miller W.T. J. Biol. Chem. 2002, 277:34634-34641. 10.1074/jbc.m203877200.
124. Lukong K.E., Richard S. Biochim. Biophys. Acta 2003, 1653:73-86. 10.1016/j.bbcan.2003.09.001.
125. Kamalati T., Jolin H.E., Mitchell P.J., Barker K.T., Jackson L.E., et al. J. Biol. Chem. 1996, 271(48):30956-30963.
126. Harvey A.J., Pennington C.J., Porter S., Burmi R.S., Edwards D.R., et al. Am. J. Pathol. 2009, 175:1226-1234. 10.2353/ajpath.2009.080811.
127. Kamalati T., Jolin H.E., Fry M.J., Crompton M.R. Oncogene 2000, 19:5471-5476.
128. Chen H.Y., Shen C.H., Tsai Y.T., Lin F.C., Huang Y.P., et al. Mol. Cell. Biol. 2004, 24:10558-10572.
129. Haegebarth A., Bie W., Yang R., Crawford S.E., Vasioukhin V., et al. Mol. Cell. Biol. 2006, 26:4949-4957.
130. Ikeda O., Miyasaka Y., Sekine Y., Mizushima A., Muromoto R., et al. Biochem. Biophys. Res. Commun. 2009, 384:71-75.
131. Zhang P., Ostrander J.H., Faivre E.J., Olsen A., Fitzsimmons D., et al. J. Biol. Chem. 2005, 280:1982-1991.
132. Born M., Quintanilla-Fend L., Braselmann H., Reich U., Richter M., et al. J. Pathol. 2005, 205:592-596.
133. Shen C.H., Chen H.Y., Lin M.S., Li F.Y., Chang C.C., et al. Cancer Res. 2008, 68:7779-7787.
134. Lofgren K.A., Ostrander J.H., Housa D., Hubbard G.K., Locatelli A., et al. Breast Cancer Res. 2011, 13:R89.
135. Ludyga N., Anastasov N., Gonzalez-Vasconcellos I., Ram M., Hofler H., et al. Mol. BioSyst. 2011, 10.1039/c0mb00286k.
136. Miah S., Martin L., Lukong K.E. Oncogenesis 2012, 10.1038/oncsis.2012.1.
137. Lukong K.E., Larocque D., Tyner A.L., Richard S. J. Biol. Chem. 2005, 280:38639-38647. 10.1074/jbc.m505802200.
138. Qiu H., Zappacosta F., Su W., Annan R.S., Miller W.T. Oncogene 2005, 24:5656-5664. 10.1038/sj.onc.1208721.
139. Liu L., Gao Y., Qiu H., Miller W.T., Poli V., et al. Oncogene 2006, 25:4904-4912. 10.1038/sj.onc.1209501.
140. Weaver A.M., Silva C.M. Breast Cancer Res. 2002, 9:R79.
141. Lukong K.E., Richard S. Cell. Signal. 2008, 20:432-442.
142. Lukong K.E., Huot M.E., Richard S. Cell. Signal. 2009, 21:1415-1422. 10.1016/j.cellsig.2009.04.008.
143. Gao Y., Cimica V., Reich N.C. J. Biol. Chem. 2012, 287:20904-20912. 10.1074/jbc.m111.334144.
144. Kang S.A., Cho H.S., Yoon J.B., Chung I.K., Lee S.T. Biochem. J. 2012, 10.1042/bj20120803.
145. Kang S.A., Lee E.S., Yoon H.Y., Randazzo P.A., Lee S.T. J. Biol. Chem. 2010, 285:26013-26021. 10.1074/jbc.m109.088971.
146. Li X., Lu Y., Liang K., Hsu J.M., Albarracin C., et al. Oncogene 2012, 10.1038/onc.2011.608.
147. Takeda H., Kawamura Y., Miura A., Mori M., Wakamatsu A., et al. J. Proteome Res. 2010, 9:5982-5993. 10.1021/pr100773t.
148. Goel R.K., Miah S., Black K., Kalra N., Dai C., et al. FEBS J. 2013, 280:4539-4559. 10.1111/febs.12420.
149. Liang X., Wisniewski D., Strife A., Shivakrupa Clarkson B., et al. J. Biol. Chem. 2002, 277:13732-13738. 10.1074/jbc.m200277200.
150. Murakami H., Yamamura Y., Shimono Y., Kawai K., Kurokawa K., et al. J. Biol. Chem. 2002, 277:32781-32790. 10.1074/jbc.m202336200.
151. Woodring P.J., Meisenhelder J., Johnson S.A., Zhou G.L., Field J., et al. J. Cell Biol. 2004, 165:493-503. 10.1083/jcb.200312171.
152. Niu Y., Roy F., Saltel F., Andrieu-Soler C., Dong W., et al. Mol. Cell. Biol. 2006, 26:4288-4301. 10.1128/mcb.01817-05.
153. Mashima R., Hishida Y., Tezuka T., Yamanashi Y. Immunol. Rev. 2009, 232:273-285. 10.1111/j.1600-065x.2009.00844.x.
154. Miah S., Goel R.K., Dai C., Kalra N., Beaton-Brown E., Bagu E.T., Bonham K., Lukong K.E. PLoS One 2014 Feb 11, 9(2):e87684. 10.1371/journal.pone.0087684.
155. King C.R., Kraus M.H., Aaronson S.A. Science 1985, 229(4717):974-976.
156. Slamondj Carklgm, Wongsg Levinwj, Ullrich A., Mcguire W.L. Science 1987, 235(4785):177-182.
157. Wolff A.C1., Hammond M.E., Hicks D.G., Dowsett M., McShane L.M., Allison K.H., Allred D.C., Bartlett J.M., Bilous M., Fitzgibbons P., Hanna W., Jenkins R.B., Mangu P.B., Paik S., Perez E.A., Press M.F., Spears P.A., Vance G.H., Viale G., Hayes D.F., American Society of Clinical Oncology, College of American Pathologists Arch. Pathol. Lab. Med. 2014, 138(2):241-256.
158. Tse C., Gauchez A.S., Jacot W., Lamy P.J. Cancer Treat. Rev. 2012, 38(2):133-142.
159. Ardavanis A., Kountourakis P., Kyriakou F., Malliou S., Mantzaris I., Garoufali A., Yiotis I., Scorilas A., Baziotis N., Rigatos G. Oncologist 2008, 13(4):361-369.
160. Kroese M., Zimmern R.L., Pinder S.E. J. R. Soc. Med. 2007, 100(7):326-329.
161. Lambros M.B., Natrajan R., Reis-Filho J.S. Hum. Pathol. 2007, 38(8):1105-1122.
162. Sauter G., Lee J., Bartlett J.M., Slamon D.J., Press M.F. J. Clin. Oncol. 2009, 27(8):1323-1333.
163. Shousha S., Peston D., Amo-Takyi B., Morgan M., Jasani B. Histopathology 2009, 54(2):248-253.
164. Lipton A., Kostler W.J., Leitzel K. Cancer 2010, 116(22):5168-5178.
165. Huang W., Weilder J., Lie Y., Whitcom J., Leinonen M., Bono P., Isola J., Kellokumpu-Lehtinen P., Bates M., Joensuu H. J. Clin. Oncol. 2009, 27(15S). (Abstract 11061).
166. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Nature 2006, 439:993-997.
167. Woodward W.A., Chen M.S., Behbod F., Rosen J.M. J. Cell Sci. 2005, 118:3585-3594.
168. Bocchinfuso W.P., Korach K.S. J. Mammary Gland Biol. Neoplasia 1997, 2:323-334.
169. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Nature 2006, 439:84-88.
170. Sleeman K.E., Kendrick H., Ashworth A., Isacke C.M., Smalley M.J. Breast Cancer Res. 2006, 8:R7.
171. Ciarloni L., Mallepell S., Brisken C. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5455-5460.
172. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
173. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. Cell Stem Cell 2007, 1:555-567.
174. Stylianou S., Clarke R.B., Brennan K. Cancer Res. 2006, 66:1517-1525.
175. Phillips T.M., McBride W.H., Pajonk F. J. Natl. Cancer Inst. 2006, 98:1777-1785.
176. Haughian J.M., Pinto M.P., Harrell J.C., Bliesner B.S., Joensuu K.M., Dye W.W., Sartorius C.A., Tan A.C., Heikkila P., Perou C.M., Horwitz K.B. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2742-2747.
177. Rizzo P., Miao H., D'Souza G., Osipo C., Yun J., Zhao H., Mascarenhas J., Wyatt D., Antico G., Hao L., Yao K., Rajan P., Hicks C., Siziopikou K., Selvaggi S., Bashir A., Bhandari D., Marchese A., Lendahl U., Qin J.Z., Tonetti D.A., Albain K., Nickoloff B.J., Miele L. Cancer Res. 2008, 68:5226-5235.
178. Fillmore C.M., Gupta P.B., Rudnick J.A., Caballero S., Keller P.J., Lander E.S., Kuperwasser C. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21737-21742.
179. Simoes B.M., Piva M., Iriondo O., Comaills V., Lopez-Ruiz J.A., Zabalza I., Mieza J.A., Acinas O., Vivanco M.D. Breast Cancer Res. Treat. 2011, 129:23-35.
180. Kim E.K., et al. Breast Cancer Res. Treat. 2011, 126:93-99.
181. deGraffenried, L.A., et al. Clin. Cancer Res. 2004, 10:8059-8067.
182. Perez-Tenorio G., Stal O. Br. J. Cancer 2002, 86:540-545.
183. Menard S., et al. Oncology 2001, 61(Suppl. 2):67-72.
184. Tokunaga E., et al. Breast Cancer 2006, 13:137-144.
185. Slamon D.J., et al. Science 1987, 235:177-182.
186. Milanezi F., Carvalho S., Schmitt F.C. Expert. Rev. Mol. Diagn. 2008, 8:417-434.
187. Siegel R., Naishadham D., Jemal A. CA Cancer J. Clin. 2012, 62:10-29.
188. Sutherland R.L., Musgrove E.A. J. Mammary Gland Biol. Neoplasia 2004, 9:95-104.
189. Gonzalez-Angulo A.M., Guarneri V., Gong Y., et al. Clin. Breast Cancer 2006, 7:326-330.
190. Stendahl M., Kronblad A., Ryden L., Emdin S., Bengtsson N.O., G Landberg Br. J. Cancer 2004, 90:1942-1948.
191. Rudas M., Lehnert M., Huynh A., et al. Clin. Cancer Res. 2008, 14:1767-1774.
192. Malumbres M. Cancer Cell 2012, 22:419-420.
193. Yu Q., Geng Y., Sicinski P. Cancer Cell 2006, 9:23-32.
194. Landis M.W., Pawlyk B.S., Li T., et al. Cancer Cell 2006, 9:13-22.
195. Sawai C.M., Freund J., Oh P., et al. Cancer Cell 2012, 22:452-465.
196. Baker S.J., Reddy E.P. Genes Cancer 2012, 3:658-669.
197. Czuczman M.S., Leonard J.P., Williams M.E. Clin. Adv. Hematol. Oncol. 2010, 8:A1-A14. (quiz A5).
198. Finn R.S., Dering J., Conklin D., et al. Breast Cancer Res. 2009, 11:R77.
199. Dean J.L., Thangavel C., McClendon A.K., Reed C.A., Knudsen E.S. Oncogene 2010, 29:4018-4032.
200. McClendon A.K., Dean J.L., Rivadeneira D.B., et al. Cell Cycle 2012, 11:2747-2755.
201. Slamon DJ H.S., Applebaum S. J. Clin. Oncol. 2010, 28(Suppl. 15):3060. (ASCO meeting abstr).
202. Finn R.S., Crown J.P., Lang I., et al. Cancer Res. 2012, 72(Suppl. 24):S1-S6. (abstr).
203. Weng A.P., Aster J.C. Curr. Opin. Genet. Dev. 2004, 14:48-54.
204. Luraguiz N. American Society of Clinical Oncology Annual Meeting 2008: Abstract 22066 2008.
205. Rasul S., Balasubramanian R., Filipovic A., et al. Br. J. Cancer 2009, 100:1879-1888.
206. Efferson C.L., Winkelmann C.T., Ware C., et al. Cancer Res. 2010, 70:2476-2484.
207. Chi A. American Society of Clinical Oncology Annual Meeting 2008: Abstract 14594 2008.
208. Wu Y., Cain-Hom C., Choy L., et al. Nature 2010, 464:1052-1057.
209. Rizzo P., Osipo C., Foreman K., et al. Oncogene 2008, 27:5124-5131.
210. Krop I. Annual Meeting: Abstract 10574 2006, American Society of Clinical Oncology.
211. Merck A Notch Signalling Pathway Inhibitor for Patients with Advanced Breast Cancer (0752-014) 2000, Clinical Trialsgov [Internet], National Library of Medicine, Bethesda, MD, (Available from: http//clinicaltrials.gov/show/NCT00106145).
212. University L. Study of MK-0752 in combination with tamoxifen or letrozole to Treat Early Stage Breast Cancer 2000, Clinical Trialsgov [Internet], National Library of Medicine (US), Bethesda, MD, (Available from: http//clinicaltrials.gov/show/NCT00756717).
213. Center UoM Phase I/II study of MK-0752 followed by Docetaxel in Advanced Metastatic Breast Cancer 2000, Clinical Trials.gov [Internet], National Library of Medicine (US), Bethesda, MD, (Available from: http://clinicaltrials.gov/show/NCT00645333).
214. Tolcher A.W., Mikulski SM W.A.M., et al. Annual Meeting 2010: Abstract 2502 2010, American Society of Clinical Oncology.
215. Institute BAKC GDC-0449 and R04929097 in Treating Women with Advanced Breast Cancer 2000, Clinical Trialsgov, National Library of Medicine (US), Bethesda, MD, (Available from: http://clinicaltrials.gov/show/NCT01071564).
216. Lawson N.D., Vogel A.M., Weinstein B.M. Dev. Cell 2002, 3:127-136.
217. Liu S., Dontu G., Wicha M.S. Breast Cancer Res. 2005, 7:86-95.
218. Blay J.Y. Ann. Oncol. 2011, 22:280-287.
219. Loewith R., et al. Mol. Cell 2002, 10:457-468.
220. Zhou H., Luo Y., Huang S. Anticancer Agents Med. Chem. 2010, 10:571-581.
221. Baselga J., et al. J. Clin. Oncol. 2005, 23:5323-5333.
222. Chan S., et al. J. Clin. Oncol. 2005, 23:5314-5322.
223. Alvarez B., et al. J. Biol. Chem. 2003, 278:26466-26473.
224. Meric-Bernstam F., Gonzalez-Angulo A.M. J. Clin. Oncol. 2009, 27:2278-2287.
225. Abraham R.T., Gibbons J.J. Clin. Cancer Res. 2007, 13:3109-3114.
226. Yao J.C., et al. J. Clin. Oncol. 2010, 28:69-76.
227. Slomovitz B.M., L.K., Johnston T., et al. J. Clin. Oncol. (Meet. Abstr.) 2008, 26:5502-5545.
228. Serra V., et al. Cancer Res. 2008, 68:8022-8030.
229. Dalenc F.C.M., Hupperets P., et al. J. Clin. Oncol. 2010, 28:1013.
230. Cardoso F., Gianni L., Jerusalem G., et al. Eur. J. Cancer Suppl. 2009, 7:261.
231. Andre F., et al. J. Clin. Oncol. 2010, 28:5110-5115.
232. Mariani G., et al. Nat. Clin. Pract. Oncol. 2009, 6:93-104.
233. Raymond E., et al. J. Clin. Oncol. 2004, 22:2336-2347.
234. Baselga J., et al. J. Clin. Oncol. 2009, 27:2630-2637.
235. Baselga J., et al. N. Engl. J. Med. 2012, 366:520-529.
236. Shor B., et al. Cell Cycle 2009, 8:3831-3837.
237. Guertin D.A., Sabatini D.M. Cancer Cell 2007, 12:9-22.
238. O'Reilly, K.E., et al. Cancer Res. 2006, 66:1500-1508.
239. Yao J.C., et al. J. Clin. Oncol. 2008, 26:4311-4318.
240. Braunstein S., et al. Mol. Cell 2007, 28:501-512.
241. Heffron T.P., et al. Bioorg. Med. Chem. Lett. 2010, 20:2408-2411.
242. Zou Z.Q., et al. Int. J. Mol. Med. 2009, 24:97-101.
243. Molckovsky A., Siu L.L. J. Hematol. Oncol. 2008, 1:20.
244. Li T., et al. J. Pharmacol. Exp. Ther. 2010, 334:830-838.
245. Garlich J.R., et al. Cancer Res. 2008, 68:206-215.
246. Maira S.M., et al. Mol. Cancer Ther. 2008, 7:1851-1863.
247. Eichhorn P.J., et al. Cancer Res. 2008, 68:9221-9230.
248. Cao P., et al. Br. J. Cancer 2009, 100:1267-1276.
249. Baumann P., et al. Exp. Cell Res. 2009, 315:485-497.
250. Feldman M.E., et al. PLoS Biol. 2009, 7:e38.
251. Liu Q., et al. Drug Discov. Today Ther. Strateg. 2009, 6:47-55.
252. Yu K., et al. Cancer Res. 2009, 69:6232-6240.
253. Garcia-Echeverria C. Bioorg. Med. Chem. Lett. 2010, 20:4308-4312.
254. Lin J.N., et al. J. Agric. Food Chem. 2010, 58:1584-1592.
255. Johnson S.M., et al. Anticancer Res. 2009, 29:3185-3190.
256. Lin Y.G., et al. Clin. Cancer Res. 2007, 13:3423-3430.
257. Beevers C.S., et al. Int. J. Cancer 2006, 119:757-764.
258. Alvarez R.H. Breast Cancer Res. 2010, 12(Suppl. 2):S1.
259. Ebos J.M., Lee C.R., Cruz-Munoz W., Bjarnason G.A., Christensen J.G., Kerbel R.S. Cancer Cell 2009, 15:232-239.
260. Paez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vinals F., Inoue M., Bergers G., Hanahan D., Casanovas O. Cancer Cell 2009, 15:220-231.
261. Loges S., Mazzone M., Hohensinner P., Carmeliet P. Cancer Cell 2009, 15:167-170.
262. Ranpura V., Hapani S., Wu S. JAMA 2011, 305:487-494.
263. Allen M., Louise Jones J. J. Pathol. 2011, 223:162-176.
264. Joyce J.A. Cancer Cell 2005, 7:513-520.
265. Holen I., Coleman R.E. Breast Cancer Res. 2010, 12:214.
266. Stopeck A.T., Lipton A., Body J.J., Steger G.G., Tonkin K., de Boer R.H., Lichinitser M., Fujiwara Y., Yardley D.A., Viniegra M., Fan M., Jiang Q., Dansey R., Jun S., Braun A. J. Clin. Oncol. 2010, 28:5132-5139.
267. Rolny C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., Squadrito M.L., Segura I., Li X., Knevels E., Costa S., Vinckier S., Dresselaer T., Åkerud P., De Mol M., Salomäki H., Phillipson M., Wyns S., Larsson E., Buysschaert I., Botling J., Himmelreich U., Van Ginderachter J.A., De Palma M., Dewerchin M., L Claesson- Welsh, Carmeliet P. Cancer Cell 2011, 19:31-44.
268. DeNardo D., Brennan D.J., Rexhepaj E., Ruffell B., Shiao S.L., Madder SF W.M.G., Wadhwani N., Keil S.D., Junaid S.A., Rugo H.S., Hwang E.S., Jirström K., West B.L., Coussens L.M. Cancer Discov. 2011, 1:54-67. (Cancer Disc 2011).
269. Pasquier E., Kavallaris M., Andre N. Nat. Rev. Clin. Oncol. 2010, 7:455-465.
270. Weaver V.M., Lelievre S., Lakins J.N., Chrenek M.A., Jones J.C., Giancotti F., Werb Z., Bissell M.J. Cancer Cell 2002, 2:205-216.
271. Hiscox S., Jordan N.J., Jiang W., Harper M., McClelland R., Smith C., Nicholson R.I. Endocr. Relat. Cancer 2006, 13:1085-1099.
272. Loeffler M., Kruger J.A., Niethammer A.G., Reisfeld R.A. J. Clin. Invest. 2006, 116:1955-1962.